Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Yumanity Therapeutics Inc (NQ: YMTX )

1.890 UNCHANGED
Last Price Updated: 4:00 PM EST, Dec 16, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.890
Bid (Size) 1.810 (9)
Ask (Size) 1.890 (3)
Prev. Close 1.890
Today's Range 1.890 - 1.890
52wk Range 10.36 - 15.54
Shares Outstanding 9,490,302
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Yumanity Therapeutics's Return On Capital Employed Insights
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga

Performance

YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
-86.43%
-86.43%
1 Year
-84.75%
-84.75%

More News

Read More
Why Planet Labs Shares Are Trading Higher; Here Are 28 Stocks Moving Premarket
Via Benzinga
Dow Surges Over 100 Points; Charter Communications Shares Slide
Via Benzinga
US Stocks Higher Ahead Of Fed Decision
Via Benzinga
Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 50 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Why Vallon Pharmaceuticals Shares Are Trading Higher By Over 150%; Here Are 29 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
VOD Stock Alert: What to Know as Vodafone Says Goodbye to CEO
Via InvestorPlace
Why Are Chinese Stocks Up Today?
Via InvestorPlace
Why Is Yumanity Therapeutics (YMTX) Stock Up Today?
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Yumanity Therapeutics Declares Special Dividend In Connection with Proposed Asset Sale to Janssen and Merger with Kineta
From Yumanity Therapeutics Inc
Via GlobeNewswire
Yumanity Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
From Yumanity Therapeutics Inc
Via GlobeNewswire
Yumanity Therapeutics Announces Effectiveness of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta, Inc.
From Yumanity Therapeutics Inc
Via GlobeNewswire
YUMANITY THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Yumanity Therapeutics, Inc. - YMTX
From Kahn Swick & Foti, LLC
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
YUMANITY THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Yumanity Therapeutics, Inc. - YMTX
From Kahn Swick & Foti, LLC
Via Business Wire
Short Volatility Alert: Yumanity Therapeutics, Inc.
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
95 Biggest Movers From Yesterday
Via Benzinga
Mid-Afternoon Market Update: Dow Turns Lower; DiDi Global Shares Surge
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.